Goodwill’s career expo planned for March 6
Goodwill Industries will bring about 30 employers to its spring career expo March 6.
The Job Connection of Goodwill Industries of the CSRA will hold the free job fair from 1-4 p.m. at the Snelling Center, 3165 Washington Road.
There will be more than 30 employers and community resources on hand with information about job openings in the Augusta area.
Those participating include the Army and Air Force Exchange Service, Augusta Marriott at the Convention Center, Cintas, Costa Layman Farms, the Georgia Department of Labor, Georgia Regents University, Kellogg, Shaw Industries, Teleperformance, University Hospital, U.S. Battery, Goodwill Industries, Helms College and Goodwill Staffing Services.
A job fair boot camp designed to prepare job-seekers will be held in both English and Spanish from 2-4 p.m. March 5 in Goodwill’s Job Connection office located next to the Snelling Center.
Coca-Cola sees profit fall in fourth quarter
NEW YORK — Coca-Cola’s fourth-quarter profit fell as the world’s biggest beverage maker once again sold less soda in North America.
The maker of Sprite, Dasani and Vitaminwater water said Tuesday that sales volume declined 1 percent in North America. That reflected a 3 percent decline in soda, which offset improved performance by noncarbonated drinks such as Powerade.
Global sales volume rose just 1 percent in the quarter.
For the three months ended Dec. 31, Coca-Cola earned $1.71 billion, or 38 cents per share. Not including one-time items such as the restructuring of its bottling operations overseas, it earned 46 cents per share, in line with Wall Street expectations.
A year ago, the company earned $1.87 billion, or 41 cents per share.
Revenue fell to $11.04 billion, short of the $11.31 billion Wall Street expected.
Its stock was down almost 3 percent at $37.84.
Actavis, Forest Labs to join in $25 billion deal
NEW YORK — Actavis PLC says it will acquire fellow drugmaker Forest Laboratories Inc. in a cash-and-stock deal worth about $25 billion.
The deal would create a combined company spanning generic and branded drugs.
Actavis will pay Forest shareholders $26.04 in cash and a portion of an Actavis share for each Forest share. The total, per-share price of $89.48 represents a premium of about 25 percent over Friday’s closing price.
Dublin-based Actavis has grown rapidly through acquisition, including an $8.5 billion deal last year to buy another Irish drugmaker, Warner Chilcott.
New York-based Forest Labs has been squeezed by generic competition to some of its biggest drugs.
On Tuesday, U.S.-traded shares of Actavis rose 5
percent to $201.47. Forest shares were up nearly 28 percent at $91.04. Both are near 52-week highs.
– From staff and wire reports